Hypobaric Hypoxia Causes Elevated Thrombin Generation Mediated by FVIII that is Balanced by Decreased Platelet Activation

Abstract

Introduction Epidemiological studies suggest that hypobaric hypoxia at high altitude poses a risk for developing venous thromboembolism. The cause of this observed hypercoagulability remains unclear. Therefore, this study aimed to investigate the effect of hypobaric hypoxia at 3,883 m above sea level on thrombin generation and platelet activation.

Methods After complying with medical ethical procedures, 18 participants were recruited, of whom 1 had to leave the study prematurely due to mild acute mountain sickness. Blood was drawn first at 50 m above sea level and second at 3,883 m altitude after gradual acclimatization for 6 days. Thrombin generation was measured in whole blood, platelet-rich plasma and platelet-poor plasma. Platelet activation was assessed using a whole blood flow-cytometric assay. Coagulation factor levels, D-dimer levels and markers of dehydration and inflammation were measured.

Results Hypobaric hypoxia at 3,883 m altitude caused increased thrombin generation, measured as peak height and endogenous thrombin potential, in whole blood, platelet-rich and platelet-poor plasma without or at low tissue factor concentration. The elevated thrombin generation was mediated by increased factor VIII levels and not caused by dehydration or inflammation. In contrast, spontaneous and agonist-induced platelet activation was decreased at high altitude.

Conclusion Hypobaric hypoxia causes increased factor VIII-mediated thrombin generation. The hypercoagulability was balanced by decreased platelet activation. These findings may explain why venous, and not arterial thrombotic events occur more frequently at high altitude.

Keywords

hypoxia - thrombin generation - platelet activation

• References

• 1 West JB. Physiological effects of chronic hypoxia. N Engl J Med 2017; 376 (20) 1965-1971
• 2 Peacock AJ. ABC of oxygen: oxygen at high altitude. BMJ 1998; 317 (7165): 1063-1066
• 3 Anand AC, Jha SK, Saha A, Sharma V, Adya CM. Thrombosis as a complication of extended stay at high altitude. Natl Med J India 2001; 14 (04) 197-201
• 4 Anand AC, Saha A, Seth AK, Chopra GS, Nair V, Sharma V. Symptomatic portal system thrombosis in soldiers due to extended stay at extreme altitude. J Gastroenterol Hepatol 2005; 20 (05) 777-783
• 5 Tyson JJ, Bjerke BP, Genuario JW, Noonan TJ. Thromboembolic events after arthroscopic knee surgery: increased risk at high elevation. Arthroscopy 2016; 32 (11) 2350-2354
• 6 Zavanone C, Panebianco M, Yger M. , et al. Cerebral venous thrombosis at high altitude: a systematic review. Rev Neurol (Paris) 2017; 173 (04) 189-193
• 7 Ninivaggi M, de Laat M, Lancé MD. , et al. Hypoxia induces a prothrombotic state independently of the physical activity. PLoS One 2015; 10 (10) e0141797
• 8 Bendz B, Rostrup M, Sevre K, Andersen TO, Sandset PM. Association between acute hypobaric hypoxia and activation of coagulation in human beings. Lancet 2000; 356 (9242): 1657-1658
• 9 Schreijer AJM, Cannegieter SC, Meijers JCM, Middeldorp S, Büller HR, Rosendaal FR. Activation of coagulation system during air travel: a crossover study. Lancet 2006; 367 (9513): 832-838
• 10 Toff WD, Jones CI, Ford I. , et al. Effect of hypobaric hypoxia, simulating conditions during long-haul air travel, on coagulation, fibrinolysis, platelet function, and endothelial activation. JAMA 2006; 295 (19) 2251-2261
• 11 Crosby A, Talbot NP, Harrison P, Keeling D, Robbins PA. Relation between acute hypoxia and activation of coagulation in human beings. Lancet 2003; 361 (9376): 2207-2208
• 12 Venemans-Jellema A, Schreijer AJM, Le Cessie S, Emmerich J, Rosendaal FR, Cannegieter SC. No effect of isolated long-term supine immobilization or profound prolonged hypoxia on blood coagulation. J Thromb Haemost 2014; 12 (06) 902-909
• 13 Martin DS, Pate JS, Vercueil A, Doyle PW, Mythen MG, Grocott MP. ; Caudwell Xtreme Everest Research Group. Reduced coagulation at high altitude identified by thromboelastography. Thromb Haemost 2012; 107 (06) 1066-1071
• 14 Redford DT, Paidy SR, Steinbrenner EB, Nielsen VG. Effects of profound hypoxemia on coagulation & fibrinolysis in normal individuals. Blood Coagul Fibrinolysis 2016; 27 (02) 228-231
• 15 Hemker HC, Al Dieri R, De Smedt E, Béguin S. Thrombin generation, a function test of the haemostatic-thrombotic system. Thromb Haemost 2006; 96 (05) 553-561
• 16 Roach RC, Bärtsch P, Hackett PH. , et al. The Lake Louise Consensus on the Quantification of Altitude Illness. Hypoxia Mol Med Burlington, VT: Queen City Press; 1993: 272-274
• 17 Ninivaggi M, Apitz-Castro R, Dargaud Y, de Laat B, Hemker HC, Lindhout T. Whole-blood thrombin generation monitored with a calibrated automated thrombogram-based assay. Clin Chem 2012; 58 (08) 1252-1259
• 18 Hemker HC, Kremers R. Data management in thrombin generation. Thromb Res 2013; 131 (01) 3-11
• 19 Hemker HC, Giesen P, Al Dieri R. , et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33 (01) 4-15
• 20 Spronk HMH, Dielis AWJH, De Smedt E. , et al. Assessment of thrombin generation II: validation of the calibrated automated thrombogram in platelet-poor plasma in a clinical laboratory. Thromb Haemost 2008; 100 (02) 362-364
• 21 Maurissen LFA, Castoldi E, Simioni P, Rosing J, Hackeng TM. Thrombin generation-based assays to measure the activity of the TFPI-protein S pathway in plasma from normal and protein S-deficient individuals. J Thromb Haemost 2010; 8 (04) 750-758
• 22 Hackeng TM, Suijlen DPL, Hemker HC. , et al. Thermostable inhibitors of activation of the blood clotting system through contact with foreign surfaces. Available at: http://www.google.com/patents/WO2013028069A1?cl=en . Accessed July 31, 2017
• 23 Roest M, van Holten TC, Fleurke G-J, Remijn JA. Platelet activation test in unprocessed blood (Pac-t-UB) to monitor platelet concentrates and whole blood of thrombocytopenic patients. Transfus Med Hemother 2013; 40 (02) 117-125
• 24 Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999; 353 (9159): 1167-1173
• 25 Gupta N, Ashraf MZ. Exposure to high altitude: a risk factor for venous thromboembolism?. Semin Thromb Hemost 2012; 38 (02) 156-163
• 26 Hackett TR, Godin JA. Editorial commentary: should the Virchow triad have been a quartet? Is high altitude a risk factor for deep venous thrombosis after knee arthroscopy?. Arthroscopy 2016; 32 (11) 2355-2356
• 27 Zafren K, Feldman J, Becker RJ, Williams SR, Weiss EA, Deloughery T. D-dimer is not elevated in asymptomatic high altitude climbers after descent to 5340 m: the Mount Everest Deep Venous Thrombosis Study (Ev-DVT). High Alt Med Biol 2011; 12 (03) 223-227
• 28 Bloemen S, Huskens D, Konings J. , et al. Interindividual variability and normal ranges of whole blood and plasma thrombin generation. J Appl Lab Med AACC Publ 2017; 2: 150
• 29 Fall L, New KJ, Evans KA, Bailey DM. Arterial hypoxaemia and its impact on coagulation: significance of altered redox homeostasis. J Clin Pathol 2015; 68 (09) 752-754
• 30 Wang J-S, Cheng M-L, Yen H-C, Lou BS, Liu HC. Vitamin E suppresses enhancement of factor VIII-dependent thrombin generation by systemic hypoxia. Stroke 2009; 40 (02) 656-659
• 31 Chatterji JC, Ohri VC, Das BK. , et al. Platelet count, platelet aggregation and fibrinogen levels following acute induction to high altitude (3200 and 3771 metres). Thromb Res 1982; 26 (03) 177-182
• 32 Vij AG. Effect of prolonged stay at high altitude on platelet aggregation and fibrinogen levels. Platelets 2009; 20 (06) 421-427
• 33 Kiouptsi K, Gambaryan S, Walter E, Walter U, Jurk K, Reinhardt C. Hypoxia impairs agonist-induced integrin α_IIbβ₃activation and platelet aggregation. Sci Rep 2017; 7 (01) 7621
• 34 Faeh D, Gutzwiller F, Bopp M. ; Swiss National Cohort Study Group. Lower mortality from coronary heart disease and stroke at higher altitudes in Switzerland. Circulation 2009; 120 (06) 495-501
• 35 Ezzati M, Horwitz MEM, Thomas DSK. , et al. Altitude, life expectancy and mortality from ischaemic heart disease, stroke, COPD and cancers: national population-based analysis of US counties. J Epidemiol Community Health 2012; 66 (07) e17
• 36 Diamond SL. Systems analysis of thrombus formation. Circ Res 2016; 118 (09) 1348-1362
• 37 Liu H, Zhang Y, Wu H. , et al. Beneficial role of erythrocyte adenosine A2B receptor-mediated AMP-activated protein kinase activation in high-altitude hypoxia. Circulation 2016; 134 (05) 405-421
• 38 Johnston-Cox HA, Yang D, Ravid K. Physiological implications of adenosine receptor-mediated platelet aggregation. J Cell Physiol 2011; 226 (01) 46-51
• 39 Iatridis PG, Hadd H, Kotrotsou M, Ling-Indeck L, Iatridis SG. Structure-function relationship of 3-phosphoglycerate analogues with platelet aggregation and thromboxane A2 formation. Haemostasis 1987; 17 (1-2): 8-13